ERBB2 and invasive carcinoma: Burkhardt and colleagues recently examined the amplification frequencies of HER2, ESR1, CCND1 and MYC in a large series of pure DCIS and DCIS associated with invasive carcinomas, and also found no significant differences between them [28].